118 related articles for article (PubMed ID: 1476756)
1. The effect of ondansetron on radiation-induced emesis and diarrhoea.
Henriksson R; Lomberg H; Israelsson G; Zackrisson B; Franzén L
Acta Oncol; 1992; 31(7):767-9. PubMed ID: 1476756
[TBL] [Abstract][Full Text] [Related]
2. [Ondansetron in the prevention of radiation-induced nausea and emesis in patients treated with single-fraction irradiation].
Jeremić B
Srp Arh Celok Lek; 1996; 124(5-6):131-4. PubMed ID: 9102832
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of an ondansetron orally disintegrating tablet: a novel oral formulation of this 5-HT(3) receptor antagonist in the treatment of fractionated radiotherapy-induced nausea and emesis. Emesis Study Group for the Ondansetron Orally Disintegrating Tablet in Radiotherapy Treatment.
LeBourgeois JP; McKenna CJ; Coster B; Feyer P; Franzén L; Goedhals L; Marzecki Z; Souhami L; Stewart A; Tønnessen F; Haigh C; Mitchell T; Wilkinson JR; Graham E
Clin Oncol (R Coll Radiol); 1999; 11(5):340-7. PubMed ID: 10591823
[TBL] [Abstract][Full Text] [Related]
4. A review of ondansetron in the management of radiotherapy-induced emesis.
Roberts JT; Priestman TJ
Oncology; 1993; 50(3):173-9. PubMed ID: 8459988
[TBL] [Abstract][Full Text] [Related]
5. Radiation-induced emesis: effects of ondansetron.
Scarantino CW; Ornitz RD; Hoffman LG; Anderson RF
Semin Oncol; 1992 Dec; 19(6 Suppl 15):38-43. PubMed ID: 1485181
[TBL] [Abstract][Full Text] [Related]
6. A randomised placebo controlled study with ondansetron in patients undergoing fractionated radiotherapy.
Franzén L; Nyman J; Hagberg H; Jakobsson M; Sorbe B; Nyth AL; Lomberg H; Henriksson R
Ann Oncol; 1996 Aug; 7(6):587-92. PubMed ID: 8879372
[TBL] [Abstract][Full Text] [Related]
7. [Efficacy of ondansetron in radiation-induced nausea and vomiting: review of the literature].
Lévy E; Paillarse JM; Votan B
Bull Cancer Radiother; 1994; 81(3):179-85. PubMed ID: 7702901
[TBL] [Abstract][Full Text] [Related]
8. Radiation-induced emesis: a prospective observational multicenter Italian trial. The Italian Group for Antiemetic Research in Radiotherapy.
Int J Radiat Oncol Biol Phys; 1999 Jun; 44(3):619-25. PubMed ID: 10348292
[TBL] [Abstract][Full Text] [Related]
9. Ondansetron. An update of its therapeutic use in chemotherapy-induced and postoperative nausea and vomiting.
Markham A; Sorkin EM
Drugs; 1993 Jun; 45(6):931-952. PubMed ID: 7691500
[TBL] [Abstract][Full Text] [Related]
10. Ondansetron: a review of its use as an antiemetic in children.
Culy CR; Bhana N; Plosker GL
Paediatr Drugs; 2001; 3(6):441-79. PubMed ID: 11437189
[TBL] [Abstract][Full Text] [Related]
11. Effectiveness of aprepitant in addition to ondansetron in the prevention of nausea and vomiting caused by fractionated radiotherapy to the upper abdomen (AVERT).
Ades S; Halyard M; Wilson K; Ashikaga T; Heimann R; Kumar S; Blackstock W
Support Care Cancer; 2017 May; 25(5):1503-1510. PubMed ID: 28032216
[TBL] [Abstract][Full Text] [Related]
12. 5-hydroxytryptamine-3 receptor antagonist with or without short-course dexamethasone in the prophylaxis of radiation induced emesis: a placebo-controlled randomized trial of the National Cancer Institute of Canada Clinical Trials Group (SC19).
; Wong RK; Paul N; Ding K; Whitehead M; Brundage M; Fyles A; Wilke D; Nabid A; Fortin A; Wilson D; McKenzie M; Ackerman I; Souhami L; Chabot P; Pater J
J Clin Oncol; 2006 Jul; 24(21):3458-64. PubMed ID: 16849762
[TBL] [Abstract][Full Text] [Related]
13. Ondansetron in the control of chemotherapy-induced and radiotherapy-induced emesis in children with malignancies.
Zoubek A; Kronberger M; Puschmann A; Gadner H
Anticancer Drugs; 1993 Dec; 4 Suppl 2():17-21. PubMed ID: 8136511
[TBL] [Abstract][Full Text] [Related]
14. Radiation-induced emesis: a problem with many open questions.
Maranzano E
Tumori; 2001; 87(4):213-8. PubMed ID: 11693797
[TBL] [Abstract][Full Text] [Related]
15. Escalating dose of oral ondansetron in the prevention of radiation induced emesis.
Maisano R; Pergolizzi S; Settineri N
Anticancer Res; 1998; 18(3B):2011-3. PubMed ID: 9677458
[TBL] [Abstract][Full Text] [Related]
16. Experience with ondansetron in chemotherapy- and radiotherapy-induced emesis.
Dicato MA; Freeman AJ
Eur J Anaesthesiol Suppl; 1992 Nov; 6():19-24. PubMed ID: 1425621
[TBL] [Abstract][Full Text] [Related]
17. Clinical studies with ondansetron in the control of radiation-induced emesis.
Priestman TJ
Eur J Cancer Clin Oncol; 1989; 25 Suppl 1():S29-33. PubMed ID: 2533896
[TBL] [Abstract][Full Text] [Related]
18. Ondansetron for efficient emesis control during total body irradiation.
Schwella N; König V; Schwerdtfeger R; Schmidt-Wolf I; Schmid H; Riess H; Siegert W
Bone Marrow Transplant; 1994 Feb; 13(2):169-71. PubMed ID: 8205086
[TBL] [Abstract][Full Text] [Related]
19. Antiemetic activity of ondansetron in acute gastroenteritis.
Cubeddu LX; Trujillo LM; Talmaciu I; Gonzalez V; Guariguata J; Seijas J; Miller IA; Paska W
Aliment Pharmacol Ther; 1997 Feb; 11(1):185-91. PubMed ID: 9042992
[TBL] [Abstract][Full Text] [Related]
20. On the mechanism of radiation-induced emesis: the role of serotonin.
Scarantino CW; Ornitz RD; Hoffman LG; Anderson RF
Int J Radiat Oncol Biol Phys; 1994 Nov; 30(4):825-30. PubMed ID: 7525517
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
